FORMULATION AND EVALUATION OF FAST DISSOLVING FILM OF LORNOXICAM

Authors

  • Zainab E Jassim Department of Pharmaceutics, College of Pharmacy, University of Baghdad, Iraq.
  • Mais F Mohammed Department of Pharmaceutics, College of Pharmacy, University of Baghdad, Iraq.
  • Zainab Ahmed Sadeq Department of Pharmaceutics, College of Pharmacy, University of Baghdad, Iraq.

DOI:

https://doi.org/10.22159/ajpcr.2018.v11i9.27098

Keywords:

Lornoxicam, Fast dissolving film, Hydroxypropyl methylcellulose E5, Polyvinyl alcohol, Solvent casting method

Abstract

Objective: The aim of the present work was to formulate and evaluate fast dissolving film containing lornoxicam.

Materials and Methods: To prepare the film, hydroxypropyl methylcellulose E5 and polyvinyl alcohol (PVA) were used as film-forming polymers by solvent casting method. Glycerine was used as plasticizer, aspartame, and mannitol as sweetener. All prepared films were evaluated for its weight variation, disintegration time, thickness, drug content, pH, dissolution study, and folding endurance. The drug-excipients compatibility study was done using differential scanning calorimetry (DSC) and Fourier transform infrared (FTIR).

Results: Satisfactory results obtained when PVA was used as film-forming polymer, and the drug was dispersed in the polymer solution using poloxamer 407 as a solubilizing agent. Formulation F2 is considered as the optimized formulation as it showed good folding endurance (>300), faster disintegration rate (30 s), and maximum in vitro drug release (87%) within 5 min. DSC and FTIR studies showed no interaction between drug and the polymers.

Conclusion: It can be concluded from the study that the fast dissolving film can be prepared for poorly water-soluble drug lornoxicam using PVA as a suitable film-forming polymer.

Downloads

Download data is not yet available.

References

Pawar SV, Junagade M. Formulation and Evaluation of mouth dissolving film of risperidone. Drug Deliv Syst 2015;9:11.

Keshavarao KP, Mudit D, Gunashekara K, Anis S, Mangla NS, Ajay K. Formulation and evaluation of mouth dissolving film containing rofecoxib. Int Res J Pharm 2011;2:273-8.

Upreti K, Kumar L, Anand SP, Chawla V. Formulation and evaluation of mouth dissolving films of paracetamol. Int J Pharm Pharm Sci 2014;6:200-2.

Chaudhary H, Gauri S, Rathee P, Kumar V. Development and optimization of fast dissolving oro-dispersible films of granisetron HCl using box–behnken statistical design. Bull Fac Pharm Cairo Univ 2013;51:193-201.

Pandya K. Fast dissolving films: A novel approach to oral drug dilivery. Int J Pharm India 2013;1:385-97.

Ulla SN, Roy AK, Sm VK. Formulation and evaluation of sustained release matrix tablets of lornoxicam. Int J Drug Dev Res 2011;3:31-44.

Patil A, Patil S. Modification of physicochemical characteristics of Lornoxicam using cyclodextrin as modulator. Int J Pharm Tech Res 2012;4:201-7.

Kalyan S, Bansal M. Recent trends in the development of oral dissolving film. Int J PharmTech Res 2012;4:725-33.

Kulkarni A, Deokule H, Mane M, Ghadge D. Exploration of different polymers for use in the formulation of oral fast dissolving strips. J Curr Pharm Res 2010;2:33-5.

Swamy N, Kumar SS. Formulation and evaluation of fast dissolving oral films of palonosetron hydrochloride using HPMC E5. Int J Pharm Chem Sci 2014;3:145-50.

Dixit GR, Chavhan JI, Upadhye KP, Misra S. Formulation and characterization of mucoadhesive buccal film of ranitidine hydrochloride using sterculia foetida gum as polymer. Asian J Pharm Clin Res 2015;8:68-71.

Gawai N, Zaheer Z. formualtion and development of mucoadhesive sustained release buccal tablets and patches of 5-fluorouracil using different polymers. Asian J Pharm Clin Res 2018;11:174-85.

Bhagwat DA. Formulation and evaluation of fast dissolving buccal patch of olmesartan medoxomil. Asian J Bio Pharm Sci 2013;3:51.

Liu C, Chang D, Zhang X, Sui H, Kong Y, Zhu R, et al. Oral fast-dissolving films containing lutein nanocrystals for improved bioavailability: formulation development, in vitro and in vivo evaluation. AAPS PharmSciTech 2017;18:2957-64.

Kapoor D. Fabrication and characterization of oral thin films of leukotrine receptor antagonist (LTRA). J Drug Deliv Therap 2015;5:77 82.

Yasmeen BR, Firoz S, Mouli YC, Vikram A, Mahitha B, Aruna U. Preparation and evaluation of oral fast dissolving films of citalopram hydrobromide. Int J Biopharm 2012;3:103-6.

Kalyanappa S, Krishna MR, Goli D. Design and in vitro evaluation of a novel sustained release double layered tablets of lornoxicam by using semi synthetic polymers. Indian J Pharm Educ Res 2015;49:281-91.

Alhalabi GF, Barakat NS, Alsulami AF, Al-Solbi AK, Shoieb BM, Alotaibi HA, et al. Formulation and evaluation of fast dissolving film of meloxicam. Int J Res in Pharmacol Pharmacother 2017;6:16-27.

Jaafar IS. Formulation and in vitro evaluation of fast dissolving film of metoclopramide hydrochloride. Int J ChemTech Res 2017;10:26-38.

Reveny J, Tanuwijaya J, Remalya A. Formulation of orally dissolving film (ODF) metoclopramide using hydroxypropylmethylcellulose and polyvinyl alcohol with solvent casting method. Int J ChemTech Res 2017;10:316-21.

Bhupinder B, Sarita J. Formulation and evaluation of fast dissolving sublingual films of rizatriptan benzoate. Int J Drug Dev Res 2012;4:133 43.

Kathpalia H, Sule B, Gupte A. Development and evaluation of orally disintegrating film of tramadol hydrochloride. Asian J BioPharma Sci 2013;3:27-32.

Sunita SS, Avinash HH. Preparation and evaluation of nanosuspensions for enhancing the dissolution of lornoxicam by antisolvent precipitation technique. Indo Am J Pharma Res 2014;4:398-405.

Dandagi PM, Dessai GA, Gadad AP, Desai VB. Formulation and evaluation of nanostructured lipid carrier (NLC) of lornoxicam. Int J Pharm Pharm Sci 2014;6:73-7.

Mhasal SN, Mali B, Narkhede MB. Drug-excipient interaction study of lornoxicam with polymers. Sch Academic J Pharm 2017;6:423-8.

Published

07-09-2018

How to Cite

Jassim, Z. E., M. F. Mohammed, and Z. A. Sadeq. “FORMULATION AND EVALUATION OF FAST DISSOLVING FILM OF LORNOXICAM”. Asian Journal of Pharmaceutical and Clinical Research, vol. 11, no. 9, Sept. 2018, pp. 217-23, doi:10.22159/ajpcr.2018.v11i9.27098.

Issue

Section

Original Article(s)